Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Gross Profit 2024–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly gross profit history and growth rate from 2025 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Cyclacel Pharmaceuticals, Inc. gross profit for the quarter ending March 31, 2026 was 143000.
- Cyclacel Pharmaceuticals, Inc. annual gross profit for 2025 was 138000.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclacel Pharmaceuticals, Inc. Gross Profit — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) gross profit over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclacel Pharmaceuticals, Inc.'s gross profit?
Cyclacel Pharmaceuticals, Inc. (BGMS) reported gross profit of $138,000 for fiscal 2025.
Where can I see BGMS's gross profit history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s gross profit by year and by quarter, including the growth rate.